GlassScriptPhysician profile
Laurel A Beverley
NPI 1285699082
$1,823.71
in general payments reported to CMS, 2019-2025
9 companies · $63.41 in 2025
The $63.41 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $1,189 · 2021: $22.41 · 2023: $235 · 2024: $151 · 2025: $63.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $1,167.09 | 2020 | |
| Innovation Technologies INC | $157.99 | 2023 | Irrisept |
| Arthrex, INC. | $140.37 | 2019 | |
| Miach Orthopaedics, INC. | $113.89 | 2024 | |
| Bioventus LLC | $65.82 | 2020-2023 | Durolane |
| Ferring Pharmaceuticals INC. | $64.03 | 2019-2024 | Euflexxa |
| Lifenet Health | $63.41 | 2025 | Theragenesis Wound Matrix |
| Lazurite INC. | $28.47 | 2023 | |
| Convatec INC. | $22.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Beverley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.